{"id":"W2555187380","doi":"10.2147/ceg.s111116","title":"HCVerso1 and 2: faldaprevir with deleobuvir (BI 207127) and ribavirin for treatment-na&amp;iuml;ve patients with chronic hepatitis C virus genotype-1b infection","year":2016,"lang":"en","type":"article","venue":"Clinical and Experimental Gastroenterology","topic":"Hepatitis C virus research","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"ca_institutions":"Boehringer Ingelheim (Canada)","funders":"Genentech; H. Lundbeck A/S; Astellas Pharma; ViiV Healthcare; Gilead Sciences; Sanofi; Pfizer","keywords":"Medicine; Ribavirin; Discontinuation; Gastroenterology; Internal medicine; Adverse effect; Nausea; Vomiting; Cirrhosis; Confidence interval; Hepatitis C virus; Immunology; Virus","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001713901,0.0008667599,0.001195068,0.0002960581,0.0003017515,0.000520393,0.0004422785,0.0008038542,0.003822017],"category_scores_gemma":[0.0008868107,0.0004704686,0.0009878376,0.0001999179,0.0005218561,0.0006083655,0.0003094627,0.00124314,0.0003449472],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005612589,"about_ca_system_score_gemma":0.001033454,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0007280809,"about_ca_topic_score_gemma":0.002874677,"domain_scores_codex":[0.999422,0.0003156076,0.00003643014,0.00006704657,0.00003930246,0.0001196338],"domain_scores_gemma":[0.999508,0.00009404706,0.00009970088,0.0000286794,0.00002063262,0.0002489587],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.8762684,0.02242349,0.007643593,0.0005246531,0.0006513504,0.0001807467,0.0001639001,0.000746544,0.01228356,0.0001738,0.0008359198,0.07810402],"study_design_scores_gemma":[0.5765444,0.3914201,0.02425184,0.00008893963,0.0004787083,0.0002993602,0.00007233299,0.00101908,0.003555484,0.0001369062,0.002091347,0.00004145918],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9976543,0.0009336681,0.0001035379,0.0001448845,0.00003832568,0.0004484852,0.0001473461,0.00001471905,0.0005146831],"genre_scores_gemma":[0.9951187,0.0007960314,0.000799365,0.0003364032,0.0001027431,0.0008159858,0.000737082,0.000006458359,0.001287265],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003822017,"threshold_uncertainty_score":0.01278597,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03663619371786352,"score_gpt":0.345651472048963,"score_spread":0.3090152783310995,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}